Latha Pathangey

Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine

Vani Lakshminarayanan, Pamela Thompson, Margreet A. Wolfert et al. · Proceedings of the National Academy of Sciences · 2011 · 298 citations · Full text

Reduced T-Cell and Dendritic Cell Function Is Related to Cyclooxygenase-2 Overexpression and Prostaglandin E2 Secretion in Patients With Breast Cancer

Barbara A. Pockaj, Gargi D. Basu, Latha Pathangey et al. · Annals of Surgical Oncology · 2004 · 168 citations

Prostaglandin E2 Secretion, Breast Oncology, Cancer Immunosurveillance +8

Cyclooxygenase-2 Inhibitor Induces Apoptosis in Breast Cancer Cells in an <i>In vivo</i> Model of Spontaneous Metastatic Breast Cancer

Gargi D. Basu, Latha Pathangey, Teresa L. Tinder et al. · Molecular Cancer Research · 2004 · 151 citations · Full text

Breast Oncology, Apoptosis, Immunology +16

Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells

Gargi D. Basu, Latha Pathangey, Teresa L. Tinder et al. · Breast Cancer Research · 2005 · 140 citations · Full text

MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model

Pinku Mukherjee, Latha Pathangey, Jillian Bradley et al. · Vaccine · 2006 · 80 citations · Full text

Muc1-specific Immune Therapy, Strong Anti-tumor Response, Cancer Immunosurveillance +10